A detailed history of Price T Rowe Associates Inc transactions in Angiodynamics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 33,772 shares of ANGO stock, worth $204,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,772
Previous 30,951 9.11%
Holding current value
$204,320
Previous $243,000 18.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.27 - $8.03 $14,866 - $22,652
2,821 Added 9.11%
33,772 $199,000
Q4 2023

Feb 14, 2024

BUY
$6.17 - $8.04 $31,658 - $41,253
5,131 Added 19.87%
30,951 $243,000
Q3 2023

Nov 14, 2023

BUY
$7.02 - $10.32 $35,591 - $52,322
5,070 Added 24.43%
25,820 $189,000
Q2 2023

Aug 14, 2023

BUY
$8.29 - $11.16 $5,322 - $7,164
642 Added 3.19%
20,750 $217,000
Q1 2023

May 15, 2023

SELL
$9.1 - $15.48 $20,384 - $34,675
-2,240 Reduced 10.02%
20,108 $208,000
Q4 2022

Feb 14, 2023

SELL
$12.06 - $21.55 $104,150 - $186,105
-8,636 Reduced 27.87%
22,348 $308,000
Q3 2022

Nov 14, 2022

SELL
$19.54 - $24.3 $60,124 - $74,771
-3,077 Reduced 9.03%
30,984 $634,000
Q2 2022

Aug 15, 2022

BUY
$17.83 - $24.49 $1,889 - $2,595
106 Added 0.31%
34,061 $659,000
Q1 2022

May 16, 2022

SELL
$20.46 - $29.16 $106,105 - $151,223
-5,186 Reduced 13.25%
33,955 $731,000
Q4 2021

Feb 14, 2022

SELL
$24.35 - $30.97 $192,365 - $244,663
-7,900 Reduced 16.79%
39,141 $1.08 Million
Q3 2021

Nov 15, 2021

BUY
$23.36 - $29.2 $3,153 - $3,942
135 Added 0.29%
47,041 $1.22 Million
Q2 2021

Aug 16, 2021

BUY
$22.39 - $28.07 $159,148 - $199,521
7,108 Added 17.86%
46,906 $1.27 Million
Q1 2021

May 17, 2021

SELL
$15.44 - $23.4 $69,788 - $105,768
-4,520 Reduced 10.2%
39,798 $931,000
Q4 2020

Feb 16, 2021

BUY
$10.34 - $15.33 $458,248 - $679,394
44,318 New
44,318 $679,000

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $237M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.